Abstract
Mesenchymal stem cells (MSCs) are potential sources of cells for tissue repair. However, little information is available about the time course of homing and differentiation of systemically delivered MSCs after acute myocardial ischemia (MI). In the present study, MSCs were isolated from male rat bone marrow and expanded in vitro. Female rats were divided randomly into three groups. Three hours after coronary ligation, the transplanted group received an infusion of MSCs through the tail vein; at the same time, a coronary-ligated control group was injected with culture medium, and a normal (unligated) group received MSCs. Homing of MSCs to the heart was assessed by expression of the Y chromosome sry gene using fluorescence in situ hybridization (FISH) at 3 days, 1, 4, and 8 weeks after transplantation. Immunofluorescent staining was used to examine markers for cardiomyocytes, endothelial cells, and smooth muscle cells. Hemodynamics in the hearts was also measured to assess cardiac function. At each time point, sry-positive cells were present in the cardiac tissue in transplanted group but not in the hearts of normal and control group animals. The number of sry-positive cells was significantly higher at 1 week compared to 3 days after transplantation. No significant difference was found in the number of sry-positive cells among those of 1, 4, and 8 weeks after transplantation. At 3 days and 1 week after transplantation, the sry-positive cells in the transplanted group lacked troponin, desmin, smooth muscle α-actin, and CD31. At the later time points, cardiomyocytes, smooth muscle cells, and endothelial cells bearing sry were identified in the transplanted group. The cardiac function in transplanted group showed higher improvement at 4 and 8 weeks compared to 1 week after transplantation. Our data suggest that intravenously delivered MSCs are capable of homing toward the ischemic myocardium, and the fastigium of homing appeared around 1 week after MI. The differentiation of MSCs to cardiomyocytes, smooth muscle cells, and endothelial cells shows to be time dependent and arises at 1 to 4 weeks after transplantation.
Similar content being viewed by others
References
Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ (2004) Stromal cell-derived factor 1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110(21):3300–3305
Anjos-Afonso F, Siapati EK, Bonnet D (2004) In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655–5664
Barbash IM, Chouraqui P, Baron J, Feinberg M, Etzion S, Tessone A (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium. Circulation 108:863–868
Bianco P, Riminucci M, Gronthos S (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192
Blau HM, Brazelton TR, Weimann JM (2001) The evolving concept of a stem cell: entity or function? Cell 105(7):829–841
Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73(6):778–886
Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000–1003
Dai WD, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA (2005) Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112:214–223
Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53:31–47
Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116:769–778
Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49
Haider HK, Ashraf M (2005) Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol 288(6):H2557–H2567
Malek S, Kaplan E, Wang JF, Ke Q, Rana JS, Chen Y, Rahim BG, Li M, Huang Q, Xiao YF, Verheugt FWA, Morgan JP, Min JY (2006) Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflügers Arch 452:268–275
Noritoshi N, Takafumi F, Takashi I, Hajime O, Takefumi I, Masaaki U (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287:H2670–H2676
Orlic D, Hill JM, Arai AE (2002) Stem cells for myocardial regeneration. Circ Res 91:1092–1102
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B (2001) Bone marrow cell regenerate infarcted myocardium. Nature 410:701–705
Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98(18):10344–10349
Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9–20
Ryan JM, Barry FP, Murphy JM, Mahon BP (2005) Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2(1):8
Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S (2001) Promotion of collateral growth by granulocyte macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104:2012–2017
Tropel P, Noel D, Platet N, Legrand P, Benabid AL, Berger F (2004) Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res 2959(2):395–406
Wollert KC, Drexler H (2005) Clinical applications of stem cells for the heart. Circ Res 96:151–163
Wollert KC, Drexler H (2005) Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation 112(2):151–153
Wurmser AE, Plamer TD, Gage FH (2004) Cellular interactions in the stem cell niche. Science 304:1253–1255
Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322–1328
Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z (2003) Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:2070–2073
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiang, W., Ma, A., Wang, T. et al. Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch - Eur J Physiol 453, 43–52 (2006). https://doi.org/10.1007/s00424-006-0117-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-006-0117-y